Haro Hartounian, Ph.D. – President & Chief Executive Officer
Dr. Haro Hartounian is a Biotechnology & Pharmaceutical executive with a record of achieving aggressive goals by positioning capital, people, intellectual property, systems, and internal disciplines for successful long-term growth.
Prior joining Vyteris, He was the CEO of Protagenic Therapeutics Inc., a biotechnology company which he founded in 2006 to develop treatments for neurological disorders. In this role, Dr. Hartounian negotiated a licensing agreement with the University of Toronto for a revolutionary central nervous system disorders technology, developed the business plan, secured seed funding, and built a world-class board of directors and scientific advisory board. Presently he serves on the Protagenics board of directors.
Prior to founding this business, Dr. Hartounian was President and COO of Microislet, Inc.; a position he held from 2001 to 2006. Dr. Hartounian led the company from start-up to a successful public company, and established Microislet as a major player in the field of cell therapy for treatment of Type 1 diabetes. While in this role, he developed the business plan and led a highly effective investment road show that secured $25 million in equity financing. His next move was to recruit a top-notch team of scientists, an outstanding board of directors and an accomplished scientific advisory board, thus ensuring positive results.
Dr. Hartounian is a member of an investment organization called the Tech Coast Angels in San Diego. He is an Entrepreneur-in-Residence with the CONNECT Springboard program assisting early-stage life science entrepreneurs in the development of their business plans and corporate strategies and is also active in numerous regional and national organizations. Dr. Hartounian was a lecturer at the Department of Bioengineering at the University of California, San Diego and Adjunct Assistant Professor at Drexel University.
Throughout his career, this blend of scientific knowledge and business acumen has allowed Dr. Hartounian to drive multiple products from bench to commercialization.
Dr. Hartounian holds a Ph. D. in Chemical Engineering from the University of Delaware, and an MS in Chemical Engineering from UCLA.
|
